Literature DB >> 19332778

Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.

Ermanno Puxeddu1, Marina Uhart, Chun-Chun Li, Faiyaz Ahmad, Gustavo Pacheco-Rodriguez, Vincent C Manganiello, Joel Moss, Martha Vaughan.   

Abstract

ADP-ribosylation factors (ARFs) have crucial roles in vesicular trafficking. Brefeldin A-inhibited guanine nucleotide-exchange proteins (BIG)1 and BIG2 catalyze the activation of class I ARFs by accelerating replacement of bound GDP with GTP. Several additional and differing actions of BIG1 and BIG2 have been described. These include the presence in BIG2 of 3 A kinase-anchoring protein (AKAP) domains, one of which is identical in BIG1. Proteins that contain AKAP sequences act as scaffolds for the assembly of PKA with other enzymes, substrates, and regulators in complexes that constitute molecular machines for the reception, transduction, and integration of signals from cAMP or other sources, which are initiated, propagated, and transmitted by chemical, electrical, or mechanical means. Specific depletion of HeLa cell PDE3A with small interfering RNA significantly decreased membrane-associated BIG1 and BIG2, which by confocal immunofluorescence microscopy were widely dispersed from an initial perinuclear Golgi concentration. Concurrently, activated ARF1-GTP was significantly decreased. Selective inhibition of PDE3A by 1-h incubation of cells with cilostamide similarly decreased membrane-associated BIG1. We suggest that decreasing PDE3A allowed cAMP to accumulate in microdomains where its enzymatic activity limited cAMP concentration. There, cAMP-activated PKA phosphorylated BIG1 and BIG2 (AKAPs for assembly of PKA, PDE3A, and other molecules), which decreased their GEP activity and thereby amounts of activated ARF1-GTP. Thus, PDE3A in these BIG1 and BIG2 AKAP complexes may contribute to the regulation of ARF function via limitation of cAMP effects with spatial and temporal specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332778      PMCID: PMC2662965          DOI: 10.1073/pnas.0901558106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes.

Authors:  Y H Choi; D Ekholm; J Krall; F Ahmad; E Degerman; V C Manganiello; M A Movsesian
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

Review 2.  A-kinase anchoring proteins take shape.

Authors:  Darren L Beene; John D Scott
Journal:  Curr Opin Cell Biol       Date:  2007-02-20       Impact factor: 8.382

3.  Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A.

Authors:  Xiaoyan Shen; Victor Meza-Carmen; Ermanno Puxeddu; Guanghui Wang; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

4.  Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.

Authors:  R Yamaji; R Adamik; K Takeda; A Togawa; G Pacheco-Rodriguez; V J Ferrans; J Moss; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Insulin-induced formation of macromolecular complexes involved in activation of cyclic nucleotide phosphodiesterase 3B (PDE3B) and its interaction with PKB.

Authors:  Faiyaz Ahmad; Rebecka Lindh; Yan Tang; Marie Weston; Eva Degerman; Vincent C Manganiello
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

6.  Overexpression of an ADP-ribosylation factor-guanine nucleotide exchange factor, BIG2, uncouples brefeldin A-induced adaptor protein-1 coat dissociation and membrane tubulation.

Authors:  Chisa Shinotsuka; Yusaku Yoshida; Kazumasa Kawamoto; Hiroyuki Takatsu; Kazuhisa Nakayama
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

7.  Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion.

Authors:  Daniel R Raymond; Lindsay S Wilson; Rhonda L Carter; Donald H Maurice
Journal:  Cell Signal       Date:  2007-08-15       Impact factor: 4.315

8.  Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.

Authors:  Fuminobu Kuroda; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

9.  Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D.

Authors:  L C Santy; J E Casanova
Journal:  J Cell Biol       Date:  2001-07-30       Impact factor: 10.539

10.  GGAs: a family of ADP ribosylation factor-binding proteins related to adaptors and associated with the Golgi complex.

Authors:  E C Dell'Angelica; R Puertollano; C Mullins; R C Aguilar; J D Vargas; L M Hartnell; J S Bonifacino
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

View more
  13 in total

Review 1.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

2.  Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.

Authors:  Kang Le; Chun-Chun Li; Guan Ye; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

3.  Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.

Authors:  Chun-Chun Li; Kang Le; Jiro Kato; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

4.  Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage.

Authors:  Saima Zafar; Matthias Schmitz; Neelam Younus; Waqas Tahir; Mohsin Shafiq; Franc Llorens; Isidre Ferrer; Olivier Andéoletti; Inga Zerr
Journal:  J Mol Neurosci       Date:  2015-04-21       Impact factor: 3.444

5.  Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1.

Authors:  George A Belov; Gennadiy Kovtunovych; Catherine L Jackson; Ellie Ehrenfeld
Journal:  Cell Microbiol       Date:  2010-10       Impact factor: 3.715

Review 6.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

Review 7.  Regulating the large Sec7 ARF guanine nucleotide exchange factors: the when, where and how of activation.

Authors:  John Wright; Richard A Kahn; Elizabeth Sztul
Journal:  Cell Mol Life Sci       Date:  2014-04-13       Impact factor: 9.261

Review 8.  ARF family G proteins and their regulators: roles in membrane transport, development and disease.

Authors:  Julie G Donaldson; Catherine L Jackson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-05-18       Impact factor: 94.444

9.  Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.

Authors:  Rune Kleppe; Inge Jonassen; Stein Ove Døskeland; Frode Selheim
Journal:  Int J Mol Sci       Date:  2018-02-19       Impact factor: 5.923

10.  Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains.

Authors:  Himabindu Penmatsa; Weiqiang Zhang; Sunitha Yarlagadda; Chunying Li; Veronica G Conoley; Junming Yue; Suleiman W Bahouth; Randal K Buddington; Guangping Zhang; Deborah J Nelson; Monal D Sonecha; Vincent Manganiello; Jeffrey J Wine; Anjaparavanda P Naren
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.